1 2 3 4 5 6 7 8 9 10 Pavel MA, Petersen EN, Wang H, Lerner RA, Hansen SB. Studies on the mechanism of general anesthesia.
Proc Natl Acad Sci U S A. 2020;117(24):13757–13766. doi:10.1073/pnas.2004259117.
McKeage K, Perry CM. Propofol: a review of its use in intensive care sedation of adults. CNS Drugs.
2003;17(4):235–272. doi:10.2165/00023210-200317040-00003.
Sahinovic MM, Struys MMRF, Absalom AR. Clinical Pharmacokinetics and Pharmacodynamics of Propofol.
Clin Pharmacokinet. 2018;57(12):1539–1558. doi:10.1007/s40262-018-0672-3.
Sumi C, Okamoto A, Tanaka H, et al. Propofol induces a metabolic switch to glycolysis and cell death in
a mitochondrial electron transport chain-dependent manner. PLoS One. 2018;13(2):e0192796. doi:10.1371/
journal.pone.0192796.
Urabe T, Yanase Y, Motoike S, et al. Propofol induces the elevation of intracellular calcium via morphological changes in intracellular organelles, including the endoplasmic reticulum and mitochondria. Eur J
Pharmacol. 2020;884:173303. doi:10.1016/j.ejphar.2020.173303.
Tsuchiya M, Asada A, Arita K, et al. Induction and mechanism of apoptotic cell death by propofol in
HL-60 cells. Acta Anaesthesiol Scand. 2002;46(9):1068–1074. doi:10.1034/j.1399-6576.2002.460903.x.
Bunte S, Behmenburg F, Eckelskemper F, et al. Cardioprotection by Humoral Factors Released after
Remote Ischemic Preconditioning Depends on Anesthetic Regimen. Crit Care Med. 2019;47(3):e250-e255.
doi:10.1097/CCM.0000000000003629.
Hausburg MA, Banton KL, Roman PE, et al. Effects of propofol on ischemia-reperfusion and traumatic
brain injury. J Crit Care. 2020;56:281–287. doi:10.1016/j.jcrc.2019.12.021.
Ulbrich F, Eisert L, Buerkle H, Goebel U, Schallner N. Propofol, but not ketamine or midazolam, exerts
neuroprotection after ischaemic injury by inhibition of Toll-like receptor 4 and nuclear factor kappa-lightchain-enhancer of activated B-cell signalling: A combined in vitro and animal study. Eur J Anaesthesiol.
2016;33(9):670–680. doi:10.1097/EJA.0000000000000449.
Li R, Huang Y, Lin J. Distinct effects of general anesthetics on lung metastasis mediated by IL-6/JAK/
STAT3 pathway in mouse models. Nat Commun. 2020;11(1):642. doi:10.1038/s41467-019-14065-6.
Nagoya J. Med. Sci. 85. 579–591, 2023
589
doi:10.18999/nagjms.85.3.579
Rui Zhou et al
11 Tian D, Tian M, Ma ZM, Zhang LL, Cui YF, Li JL. Anesthetic propofol epigenetically regulates breast
cancer trastuzumab resistance through IL-6/miR-149-5p axis. Sci Rep. 2020;10(1):8858. doi:10.1038/s41598020-65649-y.
12 Shen X, Wang D, Chen X, Peng J. Propofol inhibits proliferation, migration, invasion and promotes
apoptosis by regulating HOST2/JAK2/STAT3 signaling pathway in ovarian cancer cells. Cytotechnology.
2021;73(2):243–252. doi:10.1007/s10616-021-00462-7.
13 Zhong H, Song R, Pang Q, et al. Propofol inhibits parthanatos via ROS–ER–calcium–mitochondria signal
pathway in vivo and vitro. Cell Death Dis. 2018;9(10):932. doi:10.1038/s41419-018-0996-9.
14 Li C, Xia M, Wang H, Li W, Peng J, Jiang H. Propofol facilitates migration and invasion of oral squamous cell carcinoma cells by upregulating SNAI1 expression. Life Sci. 2020;241:117143. doi:10.1016/j.
lfs.2019.117143.
15 Zhang L, Wang N, Zhou S, Ye W, Jing G, Zhang M. Propofol induces proliferation and invasion of
gallbladder cancer cells through activation of Nrf2. J Exp Clin Cancer Res. 2012;31(1):66. doi:10.1186/17569966-31-66.
16 Malhotra GK, Yanala U, Ravipati A, Follet M, Vijayakumar M, Are C. Global trends in esophageal cancer.
J Surg Oncol. 2017;115(5):564–579. doi:10.1002/jso.24592.
17 Abbas G, Krasna M. Overview of esophageal cancer. Ann Cardiothorac Surg. 2017;6(2):131–136.
doi:10.21037/acs.2017.03.03.
18 Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established
esophageal cancer cell lines. Cancer. 1992;69(2):277–284. doi:10.1002/1097-0142(19920115)69:2<277::AIDCNCR2820690202>3.0.CO;2-C.
19 Tanaka H, Shibagaki I, Shimada Y, Wagata T, Imamura M, Ishizaki K. Characterization of p53
gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different
spectrum of mutations from primary tumors. Int J Cancer. 1996;65(3):372–376. doi:10.1002/(SICI)10970215(19960126)65:3<372::AID-IJC16>3.0.CO;2-C.
20 Barann M, Friederich P, Retzmann K, Dybek A, Urban BW. Loss of Propofol during In Vitro Experiments.
Anesthesiology. 2000;93(1):310–311. doi:10.1097/00000542-200007000-00067.
21 Husna M, Munawiroh SZ, Puji Ekawati R, Hanifah S. Systematic review of the stability and compatibility
of propofol injection. Anaesthesiol Intensive Ther. 2021;53(1):79–88. doi:10.5114/ait.2021.103542.
22 Sall JW, Leong J. Technical communication: stability of propofol in polystyrene-based tissue culture plates.
Anesth Analg. 2013;117(1):65–67. doi:10.1213/ANE.0b013e318292f32e.
23 Jiang L, Tixeira R, Caruso S, et al. Monitoring the progression of cell death and the disassembly of dying
cells by flow cytometry. Nat Protoc. 2016;11(4):655–663. doi:10.1038/nprot.2016.028.
24 Zhang F, Wang C, Cui Y, et al. Effects of Propofol on Several Membrane Characteristics of Cervical Cancer
Cell Lines. Cell Physiol Biochem. 2016;40(1–2):172–182. doi:10.1159/000452535.
25 Tatsumi K, Hirotsu A, Daijo H, Matsuyama T, Terada N, Tanaka T. Effect of propofol on androgen receptor
activity in prostate cancer cells. Eur J Pharmacol. 2017;809:242–252. doi:10.1016/j.ejphar.2017.05.046.
26 Liu F, Qiu F, Fu M, Chen H, Wang H. Propofol Reduces Epithelial to Mesenchymal Transition, Invasion and Migration of Gastric Cancer Cells through the MicroRNA-195-5p/Snail Axis. Med Sci Monit.
2020;26:e920981. doi:10.12659/MSM.920981.
27 Li H, Lu Y, Pang Y, Li M, Cheng X, Chen J. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway. Biomed Pharmacother. 2017;86:324–333. doi:10.1016/j.
biopha.2016.12.036.
28 Rigberg DA, Kim FS, Blinman TA, et al. p21 Expression Is Increased by Irradiation in Esophageal
Squamous Cell Carcinoma. J Surg Res. 1998;76(2):137–142. doi:10.1006/jsre.1998.5308.
29 Fukuoka S, Kojima T, Koga Y, et al. Preclinical efficacy of Sym004, novel anti-EGFR antibody mixture,
in esophageal squamous cell carcinoma cell lines. Oncotarget. 2017;8(7):11020–11029. doi:10.18632/
oncotarget.14209.
30 Takaishi K, Kudo Y, Kawahito S, Kitahata H. Clinically relevant concentration of propofol and benzodiazepines did not affect in vitro angiogenesis. J Anesth. 2021;35(6):870–878. doi:10.1007/s00540-021-02993-x.
31 Deng F, Ouyang M, Wang X, et al. Differential role of intravenous anesthetics in colorectal cancer
progression: implications for clinical application. Oncotarget. 2016;7(47):77087–77095. doi:10.18632/
oncotarget.12800.
Nagoya J. Med. Sci. 85. 579–591, 2023
590
doi:10.18999/nagjms.85.3.579
Propofol and esophageal cancer cell line
SUPPLEMENTARY MATERIALS
Supplementary Fig. 1 Proliferation of KYSE30 cells was suppressed by 0.5% (v/v) DMSO
but not by 0.5% (v/v) ethanol
Supplementary Fig. 1a: Experimental design to assess the effects of 0.5% (v/v) diluents (ethanol and DMSO)
on the proliferation of esophageal cancer cell lines KYSE30 and KYSE960.
Supplementary Fig. 1b: Cell numbers counted in the assay delineated in (a) (mean ± SD; n = 5). DMSO
indicates dimethyl sulfoxide. *p < 0.05.
References End
Nagoya J. Med. Sci. 85. 579–591, 2023
591
doi:10.18999/nagjms.85.3.579
...
論文の公開元へ
